Skip to main content

Effect of Treatment with β-Agonists on Tissue and Urinary Taurine Levels in Rats

Mechanism and Implications for Protection

  • Chapter
Taurine 2

Abstract

Administration of clenbuterol to rats in the drinking water over a four day period increased incorporation of [3H]leucine into muscle protein but did not result in an increase in body or muscle weight. However, both urinary and liver taurine were significantly reduced at the highest dose of clenbuterol (2 mg. kg−1 day−1). Salbutamol also reduced urinary levels of taurine in both rats and humans. The reduction in the body pool of taurine caused by β-agonists may be of concern as taurine has been shown to have protective properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azuma, J., Hamaguchi, T., Ohta, H., Takihara, K., Awata, N., Sawamura, A., Harada, H., Tanaka, Y., and Kishimoto, S. 1987, Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: possible role of taurine in its prevention, in: “The Biology of Taurine: Methods and Mechanisms,” Huxtable, R.J., Franconi, F. and Giotti, A. eds., Plenum Press, New york, pp. 167–179.

    Google Scholar 

  2. Carvalho, F., Waterfield, C.J., de Lourdes Bastos, M., Ferreira, M., and Timbrell, J.A. 1995, Effect of repeated administration of salbutamol on urinary and liver taurine levels in rats, Pharmacol.Commun. 5:171–180.

    CAS  Google Scholar 

  3. DeMaster, E.G. and Redfern, B. 1987, High-performance liquid chromatography of hepatic thiols with electrochemical detection, in: “Methods in Enzymology”, Jakoby, W.B. and Griffith, O.W. eds., Academic Press, New York City, NY., pp. 110–114.

    Google Scholar 

  4. Ellman, G.L. 1959, Tissue sulfhydryl groups, Arch.Biochem.Biophys. 82:70–77.

    Article  CAS  Google Scholar 

  5. Hasselgren, P.-O., Pedersen, P., Sax, H.C., Warner, B.W., and Fischer 1988, Current research review: Methods for studying protein synthesis and degradation in liver and skeletal muscle, J.Surg.Res. 45:389–415.

    Article  CAS  Google Scholar 

  6. Hesketh, J.E., Campbell, G.P., Lobley, G.E., Maltin, C.A., Acamovic, F., and Palmer, R.M. 1992, Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; Evidence for translational control, Comp.Biochem.Physiol. 102C:23–27.

    CAS  Google Scholar 

  7. Huxtable, R.J. 1992, Physiological actions of taurine, Physiol.Rev. 72:101–163.

    CAS  Google Scholar 

  8. Larsen, B.R., Grasso, D.S., and Chang, S.Y. 1980, A rapid method for taurine quantitation using high performance liquid chromatography, J.Chromatog.Sci. 18:233–236.

    Article  CAS  Google Scholar 

  9. Lowry, O.J., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951, Protein measurement with folin phenol reagent, J.Biol.Chem. 193:265–275.

    CAS  Google Scholar 

  10. Martineau, L., Horan, M.A., Rothwell, N.J., and Little, R.A. 1992, Salbutamol, a β2-adrenoceptor agonist, increases skeletal muscle strength in young men, Clin. Sci. 83:615–621.

    CAS  Google Scholar 

  11. McElligott, M.A., Barreto, A., Jr., and Chaung, L.-Y. 1989, Effect of continuous and intermittent clenbuterol feeding on rat growth and muscle, Comp.Biochem.Physiol. 92c: 135–138.

    CAS  Google Scholar 

  12. Nakeo, T.K., Sato, T., Nakamura, T., Taguchi, K., Moriyoshi, M., and Kawaka, K. 1992, Use of a beta 2-adrenergic stimulant (clenbuterol) for eliminating night-time calving, J. Vet.Med.Sci. 54:19–22.

    Article  Google Scholar 

  13. Potter, D.W. and Tran, T.-B. 1993, Apparent rates of glutathione turnover in rat tissues, Toxicol.Appl.Pharmacol. 120:186–192.

    Article  CAS  Google Scholar 

  14. Reeds, P.J., Hay, S.M., Dorwood, P.M., and Palmer, R.H. 1986, Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis, Br.J.Nutr. 56:249–258.

    Article  CAS  Google Scholar 

  15. Rothwell, N.J. and Stock, M.J. 1987, Effect of a selective β2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats, Biosci.Reps. 7:933–940.

    Article  CAS  Google Scholar 

  16. Siedel, J., Mullering, H., and Ziegenhorn, J. 1992, Sensitive color reagent for the enzymatic determination of creatinine, Clin.Chem. 30:968–969.

    Google Scholar 

  17. Sturman, J.A. 1993, Taurine in development, Physiol.Rev. 73:119–147.

    CAS  Google Scholar 

  18. Waterfield, C.J. 1994, Determination of taurine in biological samples and isolated hepatocytes by high-performance liquid chromatography with fluorimetric detection, J.Chromatogr.B Biomed.Appl. 657:37–45.

    Article  CAS  Google Scholar 

  19. Waterfield, C.J., Jairath, M., Asker, D.S., and Timbrell, J.A. 1995, The biochemical effects of clenbuterol: With particular reference to taurine and muscle damage, Eur.J.Pharmacol.Environ. Toxicol.Pharmacol. 293:141–149.

    Article  CAS  Google Scholar 

  20. Waterfield, C.J., Turton, J.A., Scales, M.D., and Timbrell, J.A. 1993, Effect of various non-hepatotoxic compounds on urinary and liver taurine levels in rats, Arch.Toxicol. 67:538–546.

    Article  CAS  Google Scholar 

  21. Waterfield, C.J., Turton, J.A., Scales, M.D.C., and Timbrell, J.A. 1992, The correlation between urinary and liver taurine levels and between predose urinary taurine and liver damage, Toxicology, 77:1–5.

    Article  Google Scholar 

  22. Waterfield, C.J., Turton, J.A., Scales, M.D.C., and Timbrell, J.A. 1992, Reduction of liver taurine in rats by β-alanine treatment increases carbon tetrachloride toxicity, Toxicology, 77:7–20.

    Article  Google Scholar 

  23. Yang, Y.T. and McElligott, M.A. 1989, Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue, Biochem.J. 261:1–10.

    CAS  Google Scholar 

  24. Zelikovic, I. and Chesney, R.W. 1989, Taurine, in: “New protective roles for selected nutrients”, Spiller, G.A. and Scala, J. eds., Alan R. Liss, New York, pp. 253–297.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Waterfield, C.J., Carvalho, F., Timbrell, J.A. (1996). Effect of Treatment with β-Agonists on Tissue and Urinary Taurine Levels in Rats. In: Huxtable, R.J., Azuma, J., Kuriyama, K., Nakagawa, M., Baba, A. (eds) Taurine 2. Advances in Experimental Medicine and Biology, vol 403. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0182-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0182-8_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0184-2

  • Online ISBN: 978-1-4899-0182-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics